Related Experiment Video
Updated: Apr 15, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Adjuvant therapy of mucosal melanoma
1Department of Renal Cancer and Melanoma, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Abstract:
Mucosal melanoma is a rare subtype of melanoma and associated with extremely poor prognosis. However, standard adjuvant therapy for mucosal melanoma has not been established. Some approaches have been studied to reduce the risk of recurrence in patients. These include adjuvant chemotherapy, immunotherapy, targeted therapy, and radiotherapy (RT). In this review we aim to summarize and evaluate the therapies in development.
Related Concept Videos
Tumor Immunotherapy
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

